PubMed · 10499177
Effector pathways in immune mediated central nervous system demyelination.
Abstract
Multiple sclerosis is generally regarded to be a primarily T-cell driven disease. Recent evidence has refocused interest on antibodies. Adhesion molecules, matrix metalloproteinases, chemokines and cytokines, and nitric oxide and oxygen metabolites all participate in the amplification and effector stages of the disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
B C Kieseier, M K Storch, J J Archelos, G Martino, H P Hartung. 1999. Effector pathways in immune mediated central nervous system demyelination.. https://doi.org/10.1097/00019052-199906000-00011
Cite the original work for its findings. Save a collection to share your selection of sources.